REFERENCES
- Newell FW. Endocrine disease and the eye. In: Ophthalmology Principles and Concepts. 7th ed. Chicago, IL: Mosby Year Book. 1992;cap 27:498–499.
- Duke-Elder S, Perkins ES. Diseases of the uveal tract. In: System of Ophthalmology. 4th ed. London, UK: Henry Kimpton. 1977;9:649.
- Flament J, Storck D. Eye and general pathology. Société Française d’Ophtalmologie, ed. Paris: Masson. 1997;Cap 5:165.
- Eyeson-Annan ML, Hirst LW et al. Comparative pupil dilation using phenylephrine alone or in combination with tropicamide. Ophthalmology. 1998;105(4): 726–732.
- McCormick A, Srinivasan S, Harun S, Watts M. Pupil dilation using a pledget sponge: a randomized controlled trial. Clin Experiment ophthalmol. 2006;34:545–549.
- Phillips CI. Dilate the pupil and see the fundus. BMJ. 1984;288:1779–1780.
- Barlett JR, Siderov J. Routine dilatation: Appropriate choice of technique. Clin Exp Optom. 1995;78:38–39.
- Ghose S, Garodia VK et al. Evaluation of potentiating effect of a drop of lignocaine on tropicamide-induced mydriasis. Invest Ophthalmol Vis Sci. 2001;42:1581–1585.
- Huber MJ, Smith SA, Smith SE. Mydriatic drugs for diabetic patients. Br J Ophthalmol. 1985;69(6):425–427.
- Weiss JS, Weiss JN, Greenfield DS. The effects of phenylephrine 2.5% versus phenylephrine 10% on pupillary dilation in patients with diabetes. Retina. 1995;15(2):130–133.